Amgen denied cert in Epogen case

The New York Times covered the Supreme Court's denial of cert to Amgen in the Epogen case involving defendants Aventis and Shire (May 15, 2007: Justices Turn Down Drug Patent Dispute).

**Separately,

Mondaq covered the Judge Moore opinion in the inequitable conduct case of eSpeed, Inc. v. BrokerTec USA, L.L.C., Case No. 06-1385 (Fed. Cir., Mar. 20, 2007).

**Separately,

There are concerns over a recently filed patent application by Google, which is directed to a program that could compile psychological profiles of people who play online games.